Zobrazeno 1 - 10
of 18
pro vyhledávání: '"J S, Nystrom"'
Publikováno v:
British Journal of Cancer
Beginning in 1975, 78 patients with resected stage B and C colorectal carcinoma were randomly assigned (2:1) to receive either levamisole 2.5 mg kg-1 day-1 given for 2 days every week for 18 months or placebo therapy in the same schedule. Pretreatmen
Publikováno v:
The Western journal of medicine. 164(6)
The finding of a granuloma on a bone marrow biopsy is not common. The etiologic spectrum encompasses a wide variety of disorders. We present the case of a young woman with a bone marrow granuloma and discuss the differential diagnosis, emphasizing th
Autor:
Shawn Becker, J. S. Nystrom, W. D. Henner, R. J. Hornberger, Gauri R. Varadhachary, John Hornberger, Michael G. Walker, Hialy R. Gutierrez, Mahul B. Amin
Publikováno v:
Journal of Clinical Oncology. 29:e21093-e21093
e21093 Background: An important step for validating a novel diagnostic is the assessment of its real-world clinical utility. Gene expression profiling (Pathwork Tissue of Origin Test) is recently a...
Publikováno v:
Journal of Clinical Oncology. 29:459-459
459 Background: An important step for a novel test is assessing its clinical utility and real-world effect on diagnosis and patient management. This report describes the results of a survey of physicians who have ordered a gene expression profile ass
Autor:
R J, Leonard, J S, Nystrom
Publikováno v:
Seminars in oncology. 20(3)
Publikováno v:
Journal of Clinical Oncology. 28:10579-10579
10579 Background: The Pathwork Tissue of Origin Test for FFPE is a microarray-based gene expression test that aids in the diagnosis of poorly differentiated and metastatic tumors. An accurate diagn...
Autor:
J. S. Nystrom
Publikováno v:
Archives of Internal Medicine. 137:875-879
Autor:
J. S. Nystrom
Publikováno v:
JAMA: The Journal of the American Medical Association. 241:381-383
Publikováno v:
Cancer treatment reports. 64(10-11)
Twenty-eight patients with inoperable non-small cell carcinoma of the lung were treated with high-dose methotrexate with citrovorum factor rescue. One patient (4%) responded with a partial regression of the tumor. Three patients had severe or life-th
Publikováno v:
Seminars in oncology. 4(1)
The patient with metastatic adeno- or undifferentiated carcinoma who presents with a cryptic primary is subjected to an extensive diagnostic search. These efforts apparently stem from the following assumptions: 1). The ultimately proven primary sites